A research team at has developed a new CRISPR-based gene-drive system that dramatically increases the efficiency of inactivating a gene rendering bacteria antibiotic-resistant. The new system leverages technology in insects and mammals that biases genetic inheritance of preferred traits called ‘active genetics.’